TLIK — Arzneiwerk VIDA AG Balance Sheet
0.000.00%
- €3.00m
- €13.54m
- €59.28m
- 17
- 67
- 11
- 19
Annual balance sheet for Arzneiwerk VIDA AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.013 | 0.752 | 0.391 | 1.49 | 0.299 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.31 | 0.313 | 0.463 | 4.33 | 2.13 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.377 | 1.13 | 0.89 | 11.1 | 8.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.432 | 0.311 | 0.237 | 2.57 | 3.17 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.81 | 1.44 | 3.02 | 14.4 | 11.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.25 | 0.895 | 1.42 | 14.4 | 14.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.15 | 1.64 | 1.45 | 16.6 | 16.9 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -2.34 | -0.193 | 1.57 | -2.22 | -5.1 |
Total Liabilities & Shareholders' Equity | 0.81 | 1.44 | 3.02 | 14.4 | 11.8 |
Total Common Shares Outstanding |